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Abstract
Background: A better understanding of the genetic determinants of tobacco smoking might help
in developing more effective cessation therapies, tailored to smokers' genotype. Insertion/deletion
polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) has been
linked to vulnerability to smoking and ability to quit. We aimed to determine whether 5-HTTLPR
genotype is associated with smoking behavior in Caucasians from Northern Poland and to
investigate other risk factors for tobacco smoking.
Methods: 5-HTTLPR genotypes were determined in 149 ever smokers (66 females; mean age 53.0
years) and 158 gender and ethnicity matched never smoking controls (79 females; mean age 45.0
years) to evaluate the association of this polymorphism with ever smoking status. Analysis of
smokers was performed to evaluate the role of 5-HTTLPR in the age of starting regular smoking,
the number of cigarettes smoked daily, pack-years, FTND score, duration of smoking, and the
mean length of the longest abstinence on quitting. Genotype was classified according to the
presence or absence of the short (S) allele vs. the long (L) allele of 5-HTTLPR (i.e., S/S + S/L vs. L/L).
Logistic regression analysis was also used to evaluate correlation between ever smoking and several
selected variables.
Results: We found no significant differences in the rates of S allele carriers in ever smokers and
never smokers, and no relationship was observed between any quantitative measures of smoking
and the polymorphism. Multivariate analysis demonstrated significant association between the
older age (OR = 4.03; 95% CI: 2.33–6.99) and alcohol dependence (OR = 10.23; 95% CI: 2.09–
50.18) and smoking.
Conclusion: 5-HTTLPR seems to be not a major factor determining cigarette smoking in Poles.
Probably, the risk of smoking results from a large number of genes, each contributing a small part
of the overall risk, while numerous non-genetic factors might strongly influence these genetic
undergrounds of susceptibility to smoking.
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Background
Tobacco smoking is the commonest addiction to psycho-
active substances and, being an extremely harmful behav-
ior, grossly compounds to general morbidity and
mortality. Growing evidence from classic twin studies
supports the significant influence of genetic factors in
smoking initiation and persistence, as well as the ability to
quit smoking [1,2]. Currently, studies focus on investigat-
ing candidate genes to gain a better understanding of a
molecular basis for smoking behavior [3]. However, the
precise contribution of individual genes in such a com-
plex behavior remains uncertain. It is most likely that
many genes influence it, including those that are involved
in neurotransmitter pathways and nicotine metabolism
[4].
Studies indicate that nicotine increases serotonin release
in the brain, while nicotine withdrawal has an opposite
effect [5,6]. It was hypothesized that smoking habits may
be associated with diminished serotonin (5-HT) neuro-
transmission determined by genetic polymorphism [7].
The human serotonin transporter gene (5-HTT), being
involved in serotonin reuptake, has appeared as a plausi-
ble candidate gene for susceptibility to smoking, the more
so since its link with psychological traits relevant to smok-
ing behavior was demonstrated [8,9], as well as with alco-
hol dependence, which increases the risk of tobacco
smoking [10,11]. A 44-bp insertion/deletion polymor-
phism within the promoter region (5-HTTLPR) has been
identified with two allelic variants, the long (L) and the
short (S) form, which affect the transcriptional efficiency
of the 5-HTT gene [12]. Lerman et al. [7] first hypothe-
sized that S allele might exert a protective effect against
smoking and evaluated the association of smoking prac-
tices and smoking cessation with 5-HTTLPR. However,
they did not find any significant differences in the distri-
bution of 5-HTT genotypes between smokers and non-
smokers in either Caucasian or African Americans. One of
the possible explanations for the negative results of this
initial case-control study could be the relatively small
sample size (268 current smokers vs. 230 never smokers),
which could decrease the statistical power to detect small
gene effect. However, in contrast to these results, Ishikawa
et al. [13] found in a Japanese sample of a similar size that
individuals with S/S genotype were less inclined to smoke
and/or could more easily stop smoking than others.
Results of subsequent studies, including larger sample
studies of over one thousand subjects [14], which
attempted to replicate these findings [14-17], have not
been consistent, which might result from different ethnic
backgrounds being associated with different degrees of
linkage disequilibrium with other genes loci [18]. Thus,
the hypothesized association between the low-activity S
allele and smoking remains controversial, although a
recent positron emission tomography study provided new
evidence of this possible link [19]. Therefore, there is the
need for further replication of association studies to
define the role of the 5-HTTLPR in vulnerability to smok-
ing.
Since there have been no investigations into the associa-
tion of 5-HTTLPR and smoking carried out so far in a
Polish population, we conducted the present study. The
purpose was to determine whether 5HTTLPR genotype is
associated with smoking behavior in Caucasians from
Northern Poland, as well as to investigate other risk fac-
tors for tobacco smoking.
Materials and methods
The study sample and measures
The study sample was completed among patients and staff
of the Academic Clinical Center in Gdansk and outpa-
tients of the Department of Family Medicine, the Nicolaus
Copernicus University of Torun and Collegium Medicum
in Bydgoszcz (NCUT-CMB). They were asked to complete
a questionnaire referring to socio-demographic data (age,
gender, educational level) and categorical definitions of
smoking status. Never smoker was someone, who either
had never smoked at all or had never been daily smoker
and had smoked less than 100 cigarettes (or the equiva-
lent amount of tobacco) in his lifetime [20]. Ever smokers
were defined as individuals who had smoked at least 100
cigarettes in their lifetime [20]. Current smokers were
defined as individuals who, at the time of the survey,
smoked cigarettes either daily or occasionally [20].
Former smokers were defined as those who had quit
smoking at least 1 year before the study. To verify recent
non-smoking status, the measurement of carbon oxide in
exhaled air was performed in former smokers with the use
of Micro CO smokelyser (Bedfont Instruments, Kent, UK).
The level of education was recorded as primary, voca-
tional, high and university. Three hundred and ten adult
subjects, including 150 ever smokers (cases) and 160 gen-
der matched never smoking controls, were recruited. All
of them were Caucasians from the North of Poland.
Several quantitative measures of smoking behavior were
also completed with the use of the questionnaire. They
included: age of starting regular smoking, number of cig-
arettes smoked, and number of years of smoking. Pack-
years were calculated using the average number of ciga-
rettes smoked daily and the number of years smoked. Cur-
rent daily smokers were also asked to complete the
Fagerstrom Test for Nicotine Dependence [21] and give
the longest abstinence period on quitting attempt. All
reported periods of maximal abstinence were further cal-
culated into days.
In addition, information on recent or prior treatment due
to any psychiatric disorders (diagnosis and medications)BMC Medical Genetics 2008, 9:76 http://www.biomedcentral.com/1471-2350/9/76
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and on alcohol dependence was obtained from respond-
ents by self-report.
From all participants of the study, 8-mm of venous blood
sample was collected into heparinized tubes. Samples
were frozen and stored at -80°C until required for molec-
ular genotypic analyses.
The institutional research ethics committees at the Medi-
cal University of Gdansk and the Nicolaus Copernicus
University of Torun approved all study procedures, and all
subjects provided written, informed consent prior to par-
ticipation in the study.
Genotyping
Genomic DNA was extracted from lymphocytes by an
enzymatic method using a commercial kit Blood DNA Prep
Plus (A&A Biotechnology, Gdynia) and used as a template
for the PCR. 5-HTTLPR genotyping was performed with
the use of oligonucleotide primers flanking the 5-HTTLPR
as described by Heils et al. [12], and with a few modifica-
tions [22]. The set of primers used was as follows:
sense: 5'-GGCGTTGCCGCTCTGAATGC-3';
antisense: 5'-GAGGGACTGAGCTGGACAACCAC-3'.
Statistical analyses
The chi-squared (χ2) test was used to asses the deviations
of genotype distribution from the Hardy-Weinberg equi-
librium and for group comparisons of frequencies of
allele and genotype. Logistic regression analysis, using
STATISTICA 7.1 software (StatSoft Inc., USA), was used to
estimate correlations. Variables which appeared to be
associated with any increased risk for smoking status in
the univariate analysis were analyzed by multivariate
analysis. The association between these variables and
smoking was expressed as crude and adjusted odds ratios
(Ors) with 95% confidence intervals (95% CIs). Student's
test t was used to compare means for continuous varia-
bles. Because of the non-normal distribution of most
parameters, nonparametric Mann-Whitney U test was
applied for two-group comparisons. Data have been
expressed as means ± standard deviation (SD). A signifi-
cance level of 0.05 was set for a type 1 error in all analyses.
Results
Three participants did not undergo genotyping success-
fully; they were, therefore, excluded from further investi-
gation. As a result, the final sample for analysis consisted
of 307 subjects, including 149 ever smokers (66 females;
mean age 53.0 ± 11.2 years) and 158 never smokers (79
females; mean age 45.0 ± 16.2 years).
Distribution of 5-HTTLPR genotypes did not deviate sig-
nificantly from the Hardy-Weinberg expectation, as deter-
mined by the chi-square test (χ2 = 0.80, df = 1; p = 0.37)
With carriers defined as subjects who tested positive for
the presence of the allelic variants, whether homozygous
or heterozygous (i.e., S/S, S/L), we found that 58% of the
sample (n = 178) carried S allele (n = 42 homozygous),
while 42% (n = 129) did not (i.e., L/L). Frequencies of L
and S allele, as well as short allele carriers and non-carri-
ers, did not differ significantly in ever and never smokers
(χ2 = 1.71, df = 1; p = 0.19, and χ2 = 1.03; df = 1; p = 0.31,
respectively). Similarly, there were no significant differ-
ence in the distribution of 5-HTTLPR L and S alleles and
genotypes in current and never smokers, as well as in cur-
rent and former smokers. Allele frequencies and geno-
types for the 5-HTT gene by smoking status can be found
in Table 1.
In the smokers group, no association was observed
between any quantitative measures of smoking and the
polymorphism (Table 2).
Out of the total of 307 participants, 23 subjects (7.5%; 15
females) reported current or prior treatment because of
psychiatric disorders, including depression or anxiety-
related disorders (20 subjects) and schizophrenia (3 sub-
jects). Cited medications were in agreement with self-
reported psychiatric diagnoses and included inhibitors of
selective serotonine transporter (15 subjects), tricyclic
antidepressants (4 subjects), neuroleptics (3 subjects),
and anxiolytics (1 subject). There were 6 (26%) never
smokers and 17 (74%) current smokers, while there were
Table 1: Distribution of 5-HTTLPR L and Seles and genotypes according to smoking status in the surveyed population from the North of 
Poland
Smoking status No. (%) of allele No. (%) of genotype
LS L / L L / S S / S
Ever smokers 199 (66.8) 99 (33.2) 67 (45) 65 (43.6) 17 (11.4)
Current smokers 131 (66.2) 67 (33.8) 43 (43.4) 45 (45.5) 11 (11.1)
Former smokers 68 (68) 32 (32) 24 (48) 20 (40) 6 (12)
Never smokers 195 (61.7) 121 (38.3) 62 (39.2) 71 (44.9) 25 (15.8)BMC Medical Genetics 2008, 9:76 http://www.biomedcentral.com/1471-2350/9/76
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no former smokers among them. The rate of ever smokers
among subjects reporting mental health problems was
significantly higher than in other subjects (74% vs.
46.5%; p = 0.011). Seventeen subjects (5.5%; 3 females)
in the study group mentioned alcohol dependence in the
self-report. There were 15 ever smokers (88%) and two
never smokers among them (12%). The frequency of
smoking in alcoholics was significantly higher in compar-
ison to non-alcoholic subjects (88% vs. 46%; p = 0.0018).
We found no differences in frequencies of S and L alleles
between subjects with psychiatric disorders or alcohol
dependence and remaining subjects (p = 0.64 and p =
0.91, respectively).
In univariate logistic regression analyses, the following
variables appeared to be associated with an increased risk
for ever smoking status (i.e., smoking initiation): older
age, a history of psychiatric disorders and alcohol depend-
ence. Gender was not considered in these analyses
because of the gender-matching of the study sample.
Multivariate regression analysis demonstrated a signifi-
cant association between the older age and alcohol
dependence and smoking, while adjusted odds ratio for
smoking for subjects with psychiatric disorders nearly
reached statistical significance (Table 3).
The results of the separate analyses on the association
between  5-HTTLPR  and smoking, performed in more
homogenous groups of ever and never smokers obtained
by excluding subjects with psychiatric disorders and/or
alcohol dependence, did not differ significantly from
results of analyses performed in the whole study sample.
Frequencies of L and S allele, as well as short allele carriers
and non-carriers did not still differ significantly in ever
and never smokers (χ2 = 1.87, df = 1, p = 0.17, and χ2 =
1.43, df = 1, p = 0.23, respectively). Similarly, we consist-
ently found no association between any quantitative
measures of smoking and the polymorphism in the smok-
ers group (Table 4). Further, the results of multivariate
analysis of the association between ever tobacco smoking
and 5-HTTLPR, age, and the level of education (adjusted
ORs and 95% CI: 0.76, 0.43–1.34; 4.72, 2.63–8.46; 1.07,
0.57–2.01, respectively) were consistent with those when
it was performed in the whole study sample.
Discussion
In the surveyed population from the North of Poland, we
found 36% of carriers of the 5-HTTLPR  short variant
allele. This rate was approximate to 34% found by another
Polish research group [23], somewhat lower than those
reported in two studies conducted in European Ameri-
cans, where S allele was found in 40% and 43% of sub-
jects, respectively, and somewhat higher than the rates
found in African American participants of these studies,
i.e., 30% and 31%, respectively [7,24]. In turn, the consid-
erably lower rate of S allele was found in two studies con-
ducted in Japanese populations – 16% and 19% [13,24].
These differences between 5-HTTLPR allele frequencies in
various populations reflect their racial and ethnic genetic
differentiation [24].
We found no association between 5-HTTLPR and smok-
ing status, as well as any quantitative measure of smoking,
Table 2: Values for smoking characteristics by 5-HTTLPR genotype in ever smokers
Characteristic Mean (SD) P value
S/S+S/L L/L
Duration of smoking 27.4 ± 11.9 26.9 ± 12.7 0.76
No. of cigarettes smoked daily 19.6 ± 10.5 18.2 ± 8.9 0.58
No of pack/years 27.3 ± 20.0 22.4 ± 12.8 0.32
Age of proceeding to regular smoking 19.9 ± 4.5 20.5 ± 5.3 0.76
FTND score* 5.5 ± 2.5 5.3 ± 2.0 0.66
Duration of the longest abstinence in quitting attempts* 368.6 ± 1102.3 211.6 ± 388.2 0.90
*only current daily smokers were analysed
Table 3: Multivariate analysis of the association between ever tobacco smoking and selected variables
Variables Crude ORs (95% CI) Adjusted ORs (95% CI)*
S/S + S/L genotype 0.79 (0.50–1.25) 0.78 (0.46–1.33)
Age ≥ 50 years 3.13 (1.96–5.00) 4.03 (2.33–6.99)
Lower education (primary/vocational) 1.36 (0.82–2.24) 0.98 (0.54–1.79)
Psychiatric disorder + 3.26 (1.25–8.55) 2.90 (0.98–8.55)
Alcohol dependence + 8.73 (1.95–39.13) 10.23 (2.09–50.18)
*Adjusted ORs are adjusted for all other items in the multivariate modelBMC Medical Genetics 2008, 9:76 http://www.biomedcentral.com/1471-2350/9/76
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such as the number of cigarettes smoked daily, the
number of pack-years, FTND score, or the duration of the
longest abstinence period on quitting. To date, only a few
studies, in contrast to our findings, supported a link
between 5-HTTLPR and smoking, and demonstrated that
individuals with the L allele were more inclined to smoke
and/or had more difficulties with quitting smoking than
others [13,15]. Other studies failed to replicate these pos-
itive results, including the more recent report of Trummer
et al., who found additionally that neither smoking status
nor Fagerstrom Tolerance Questionnaire score, pack-
years, number of cigarettes smoked daily or previous
attempts to quit smoking were related to 5-HTT genotypes
[7,14]. It should be noted, however, that several factors
may have a substantial impact on the outcome of associa-
tion studies and contribute to their inconsistency [3,18].
The most important is population heterogeneity, as
regards ethnicity, gender or age, and possible stratifica-
tion. Further, interacting effects, such as environment and
personality, are considered to play an important role [25].
Between-study heterogeneity results also from the various
categorical definitions of never smokers, current smokers
and former smokers adopted in particular studies, as well
as from differences in the mean number of cigarettes
smoked per day or mean values of other quantitative
measures of smoking behavior in smokers used in studies.
If we compare, for instance, our survey to the Israeli study
[15] which reported a highly significant association
between 5-HTTLPR genotype and smoking behavior, irre-
spective of dependence level, several essential differences
regarding both populations might be found. Apart from
population ancestry, the younger age of the participants of
the Israeli survey seems to be one of them, with the aver-
age age of ever smokers being 29 years. In addition, smok-
ers in this study group were mainly light smokers, not
biologically dependent on nicotine (i.e., they had a FTND
score lower than 6), while, in our study population, half
of current smokers were highly addicted subjects. It is
likely that these differences could influence the results of
these two studies. Moreover, probably the effect of poly-
morphism is related to socio-cultural settings and ethnic-
ity and may be less marked in populations of such
countries like Poland, where smoking was a "national
habit" for decades [26]. Ever smokers in our material were
recruited mostly from individuals who had started smok-
ing at a particular socio-political period of Polish history,
which influenced the style of life of Poles with an
extremely high consumption of cigarettes [26]. We found
that subjects aged 50 years or older had an over three
times higher risk of smoking than younger subjects. It is
possible that possession of S  allele, hypothesized to
increase dopamine availability in midbrain, was not
enough to protect from smoking in such a disadvanta-
geous environment. Thus, non-replication of association
studies may result from a small effect of a single gene and
the relatively greater influence of a number of environ-
mental factors on smoking. The link of the 5-HTTLPR or
other candidate gene polymorphism with smoking might
emerge in a given population when smoking rates decline
due to the predominance of non-genetic factors, including
positive changes in the attitudes to smoking of the popu-
lation as a whole.
It appears essential in case-control genetic association
studies to precise defining of smoking phenotypes. The
method of classification of ever smokers may have an
impact on the results of the study [27]. It is suggested, that
a significant amount of information on the resistance to
regular smoking might be emerged with defining individ-
uals who have smoked 1–99 cigarettes in their lifetime as
ever smokers, not never smokers according to WHO
[18,27]. It is also suggested, that genuine never smokers,
who had never smoked even one cigarette (or even one
puff) may be highly genetically informative [3]. However,
in our study conducted in the population of extremely
high prevalence of smoking by decades, subjects having
smoked up to 100 cigarettes in their lifetime were consid-
ered never smokers.
Because of the divergent results of association studies, evi-
dence for a substantial role of the 5-HTT gene in smoking
behavior is not strong to date. Additionally, meta-analysis
Table 4: Values for smoking characteristics by 5-HTTLPR genotype in ever smokers after excluding subjects with self-reported 
psychiatric disorders and/or alcohol dependence
Characteristic Mean (SD) P value
S/S+S/L L/L
Duration of smoking 24.8 ± 11.0 28.0 ± 13.1 0.18
No. of cigarettes smoked daily 18.0 ± 9.2 17.1 ± 8.5 0.73
No of pack/years 22.9 ± 15.0 16.1 ± 17.4 0.73
Age of proceeding to regular smoking 20.6 ± 4.3 20.5 ± 4.7 0.76
FTND score* 5.1 ± 2.4 5.2 ± 2.0 0.79
Duration of the longest abstinence in quitting attempts* 413.9 ± 1482.3 265.9 ± 446.4 0.29
*only current daily smokers were analysedBMC Medical Genetics 2008, 9:76 http://www.biomedcentral.com/1471-2350/9/76
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of studies on association between the 5-HTTLPR  and
smoking behavior [3] did not suggest an effect of this pol-
ymorphism on initiating, adopting and persisting with
smoking. However, when only the studies which reported
data on the 5-HTTLPR polymorphism that pertained to
smoking cessation were analyzed, a significant effect was
revealed. It is likely that the presence of a variant allele
may be associated with an increased likelihood of success-
ful smoking cessation. In our study, the comparison of the
mean length of the self-reported longest abstinence on
quitting did not reveal significant differences between S
allele carriers and non-carriers, which indirectly indicated
that ability to quit might not be related to the 5-HTTLPR
genotype. Other genes, non-genetic factors, personality
and motivation to quit might contribute a greater effect in
smoking cessation.
Growing evidence indicates that smoking behavior and
ability to quit are influenced by personality traits, includ-
ing neuroticism, and psychiatric disorders or alcohol
dependence [28,29]. On the other hand, several studies
demonstrated the association between the 5-HTTLPR and
alcohol dependence or neuroticism, as well as depression
and anxiety, which correlate well with this personality
trait [10,11,30,31]. Data suggested also that smoking
behavior is influenced by an interaction between neuroti-
cism and 5-HTTLPR genotype [32]. More recently, how-
ever, a number of studies demonstrated that although
neuroticism and depression vulnerability were associated
with smoking behavior, genotype did not affect this rela-
tionship [33,34].
Undergoing treatment for alcohol addiction and/or the
presence of psychiatric disorders was an exclusion crite-
rion imposed on subjects' eligibility for some of the earlier
association studies on 5-HTTLPR to avoid a possible con-
founding effect on the distribution of genotypes in smok-
ers and non-smokers [7,13]. In the present study, this
exclusion criterion was not adopted, although for exam-
ple the results of other Polish researchers indicated an
importance of careful inclusion of probands in studies on
association between 5-HTTLPR  and personality traits
[22,35], which in turn may affect smoking status. The fact
that we found no differences in the frequencies of S and L
alleles between subjects with psychiatric disorders or alco-
hol dependence and remaining subjects might suggest the
lack of associations between psychiatric disorders and
alcohol dependence and 5-HTT genotype. However, the
group size of subjects reporting these problems seems too
small to generalize the results of this study, especially as
regards the link of 5-HTTLPR  with separate psychiatric
diagnoses. In several studies which focused on the inves-
tigation of a possible link of 5-HTTLPR with affective dis-
orders, a positive association was found [30,31], while
other studies have not supported this [36-38]. Thus, the
relationship between this polymorphism and affective
disorders remains uncertain. Our study let us only support
earlier observations that individuals with psychiatric dis-
orders and alcohol dependence are more likely to smoke
cigarettes [29].
Several limitations of the study should be pointed out.
Firstly, the study sample was relatively small, while sam-
ple size in thousands of subjects might be more sufficient
to detect small genetic effects, which are likely for single
loci and complex smoking behavior. However, several
studies on the link of 5-HTTLPR with smoking have been
recently conducted in smaller samples, which included
several hundreds of subjects, and positive association was
reported [15-17]. This incited us to investigate the poten-
tial association between 5-HTTLPR and smoking in the
sample of a similar size in Polish population. Secondly,
we have not genotyped a SNP within the 5-HTTLPR [39],
which could modify the effect of the L allele. Further, the
smoking status has been verified with the measurement of
exhaled CO concentration only in former smokers (i.e.,
those smokers who had quit smoking at least 1 year before
the study) to avoid the classification error attributed to
self-report [40]. In turn, we did not expect this bias toward
a socially desirable response in never smokers and current
smokers, therefore biochemical verification of smoking
status was not performed in these groups. Finally, partici-
pants' self-reports of their psychiatric disorders were not
confirmed by a formal clinical interview or checking med-
ical documentation, but only confronted with cited phar-
macological treatment. However, the main purpose of the
present study was to assess the relationship between 5-
HTTLPR and smoking, and psychiatric disorders in gen-
eral, as well as alcohol dependence, served only as covari-
ates in our analyses.
Conclusion
In spite of potential limitations, the results of our study
allow us to conclude that 5-HTTLPR is not a major factor
determining cigarette smoking in Poles. Probably, the risk
of smoking results from a large number of genes, each
contributing a small part of the overall risk, while numer-
ous non-genetic factors might strongly influence these
genetic undergrounds of susceptibility to smoking. A bet-
ter understanding of the genetic determinants of smoking
needs further investigation into the interactions of genes
involved in synthesis, release, uptake and receptor func-
tion for a variety of neurotransmitters, as well as into
establishing the interactions between the 5-HTTLPR poly-
morphism and psychological traits.
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